[
    "{\"step_by_step_thinking\": \"Ofatumumab is a monoclonal antibody that targets CD20, a protein found on the surface of B cells. It is approved for the treatment of relapsing forms of multiple sclerosis (MS) in adults. It works by binding to CD20 on B cells and depleting them from the circulation, which helps to reduce inflammation and prevent relapses in MS. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]